SCHEMBL8174707

SCHEMBL8174707

COc1ccccc1N(C)c1ccc(Cn2cc(CC(=O)O)c3ccccc32)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ ICMT O60725 1/20 0.48
▸ HTR6 P50406 2/20 0.47
▸ PPARG P37231 1/20 0.47
▸ PPARD Q03181 1/20 0.47
▸ PPARA Q07869 1/20 0.47
▸ HDAC6 Q9UBN7 3/20 0.46
▸ HDAC1 Q13547 2/20 0.46
▸ HDAC2 Q92769 2/20 0.46
▸ HDAC10 Q969S8 2/20 0.45
▸ PLA2G2A P14555 1/20 0.45
▸ MCL1 Q07820 1/20 0.45
▸ HDAC3 O15379 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ NCOR2 Q9Y618 1/20 0.45
▸ CDC25A P30304 1/20 0.45
▸ PLK1 P53350 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ S1PR2 O95136 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8174718 0.90 PLA2G2A (0.53) ALDH1A1LMNAICMTHTR6PPARG
SCHEMBL8180790 0.90 PLA2G2A (0.53) ALDH1A1LMNAICMTHTR6PPARG
SCHEMBL13931435 0.89 LMNA (0.58) ALDH1A1LMNAICMTHTR6PPARG
SCHEMBL8178984 0.87 LMNA (0.57) ALDH1A1LMNAICMTHTR6PPARG
SCHEMBL8175094 0.87 HTR6 (0.61) ALDH1A1LMNAHTR6PPARGPPARD
SCHEMBL8174701 0.87 ALDH1A1 (0.58) ALDH1A1LMNAHTR6HDAC6HDAC1
SCHEMBL13931033 0.86 ALDH1A1 (0.65) ALDH1A1LMNAHTR6HDAC6HDAC1
SCHEMBL8175273 0.86 ALDH1A1 (0.54) ALDH1A1LMNAHTR6HDAC6HDAC1
SCHEMBL8174660 0.84 ALDH1A1 (0.60) ALDH1A1LMNAHTR6PPARDHDAC6
SCHEMBL8169900 0.84 LMNA (0.58) ALDH1A1LMNAHTR6PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047246-A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-02-19 — — US disclosed
US-20090047246-A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-02-19 — — US disclosed
WO-2008100867-A2 NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2008-08-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047246-A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION EIF2AK2, HAVCR2, HCCS ALDH1A1 1836/4885LMNA 2969/4885ICMT 2415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback